Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Prophylactic dex at absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity; dex attenuated facial nerve palsy, but not IEC-DNT, -PKS, -NP.”
Title: Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity
Authors: Kenneth JC Lim, Melinda Tan, Ricardo Parrondo, Saurabh Chhabra, Christoph Schaefers, Katharine Dooley, Andre De Menezes Silva Corraes, Malvika Gupta, Darin Carabenciov, Morie Gertz, Lisa Hwa, Stephens Haily, Prashant Kapoor, Taxiarchis Kourelis, Rahma Warsame, Joselle Cook, Moritz Binder, Nadine Abdallah, Saurabh Zanwar, P. Leif Bergsagel, Udit Yadav, Erin Wiedmeier-Nutor, Susan Geyer, Sikander Ailawadhi, Rafael Fonseca, Shaji Kumar, Anastasia Zekeridou, Yi Linsvg
You can read the full article on Blood Cancer Journal.

You can find other articles featuring Robert Orlowski on OncoDaily.